日水製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2012/07/27 | 日証協 | 7,400株 | +2.78% | 500株 | 0% | 56,033株 | -1.41% | 7,000株 | +180% |
| 2012/07/20 | 日証協 | 7,200株 | -2.7% | 0株 | -100% | 56,833株 | -0.35% | 2,500株 | -47.92% |
| 2012/07/13 | 日証協 | 7,400株 | -7.5% | 300株 | -85% | 57,033株 | -2.56% | 4,800株 | -4.02% |
| 2012/07/06 | 日証協 | 8,000株 | +86.05% | 2,000株 | -31.03% | 58,534株 | -15.21% | 5,001株 | +77.66% |
| 2012/06/29 | 日証協 | 4,300株 | -41.1% | 2,900株 | -50% | 69,033株 | +17.77% | 2,815株 | -19.57% |
| 2012/06/22 | 日証協 | 7,300株 | +192% | 5,800株 | +383.33% | 58,618株 | +4.45% | 3,500株 | -59.77% |
| 2012/06/15 | 日証協 | 2,500株 | +4.17% | 1,200株 | -20% | 56,118株 | +8.51% | 8,700株 | +27.94% |
| 2012/06/08 | 日証協 | 2,400株 | +14.29% | 1,500株 | -11.76% | 51,718株 | +8.38% | 6,800株 | +6.25% |
| 2012/06/01 | 日証協 | 2,100株 | -57.14% | 1,700株 | -77.33% | 47,718株 | -3.83% | 6,400株 | +68.42% |
| 2012/05/25 | 日証協 | 4,900株 | +28.95% | 7,500株 | +102.7% | 49,618株 | -20.12% | 3,800株 | +72.73% |
| 2012/05/18 | 日証協 | 3,800株 | +15.15% | 3,700株 | -77.3% | 62,118株 | +2.47% | 2,200株 | +57.14% |
| 2012/05/11 | 日証協 | 3,300株 | -13.16% | 16,300株 | +150.77% | 60,618株 | 0% | 1,400株 | 0% |
| 2012/05/02 | 日証協 | 3,800株 | +11.76% | 6,500株 | -33.67% | 60,618株 | +0.17% | 0株 | -100% |
| 2012/04/27 | 日証協 | 3,400株 | -19.05% | 9,800株 | +20.99% | 60,518株 | -0.49% | 700株 | -46.15% |
| 2012/04/20 | 日証協 | 4,200株 | -23.64% | 8,100株 | -28.32% | 60,818株 | +5.92% | 1,300株 | -23.53% |
| 2012/04/13 | 日証協 | 5,500株 | -21.43% | 11,300株 | -48.87% | 57,418株 | -4.65% | 1,700株 | -92.24% |
| 2012/04/06 | 日証協 | 7,000株 | +59.09% | 22,100株 | +135.11% | 60,218株 | +119.77% | 21,900株 | +5.71% |
| 2012/03/30 | 日証協 | 4,400株 | -49.43% | 9,400株 | +27.03% | 27,400株 | -57.13% | 20,718株 | +263.22% |
| 2012/03/23 | 日証協 | 8,700株 | +40.32% | 7,400株 | -35.65% | 63,919株 | +25.25% | 5,704株 | -73.22% |
※株式分割は考慮していませんのでご注意ください。